;

Search Results:

Showing of 50

CLINICAL TRIAL16480

Radiomics: A Prospective Study of Outcome in Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL17723

Expansion of Enduring Infrastructure to Support Lung Cancer Screening Research

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18431

A Screening Protocol to Determine Tumor Antigen Expression and HLA Sub-Type for Eligibility Determination for Clinical Trials Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs in Subjects with Non-Small Cell Lung Cancer (NSCLC)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18611

The Gut Microbiome and Immunotherapy in Non-small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18558

A Phase 1B/2 Open-Label Study to Evaluate Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB00100718C) in Combination with Other Cancer Immunotherapies in Patients with Advanced Malignancies

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18522

A Phase I Dose Escalation Open Label Clinical Trial Evaluating the Safety and Efficacy of MAGE-A10c796T in Subjects with Stage IIIb or Stage IV Non-Small Cell Lung Cancer (NSCLC)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18515

Symptoms, Toxicity Prevalence and Quality of Life Benefit of Targeted Therapies and Immunotherapies in Lung Cancer Patients: An Observational Prospective Cohort Study within the Total Cancer Care Population

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL17971

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18855

Multicenter, Open-label, Phase 1, Dose-escalation,Cohort-expansion, First-in-Human Study of KHK2455 Administered as Monotherapy and in Combination with Mogamulizumab (KW-0761) in Adult Subjects with Locally Advanced or Metastatic Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18555

A Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18197

A Phase 2 Study of MM-121 in Combination with Docetaxel or Pemetrexed versus Docetaxel or Pemetrexed Alone in Patients with Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18503

STARTRK-2: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18342

A Pilot Open Label Clinical Trial Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs Specific for NY-ESO-1 in Subjects with Stage IIIb or Stage IV Non-Small Cell Lung Cancer (NSCLC)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL17986

Phase 1 Study of Mogamulizumab (KW-0761) in Combination with MEDI4736 (Durvalumab) and Mogamulizumab in Combination with Tremelimumab in Subjects with Advanced Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18398

Novartis Pharmaceuticals trial entitled: A phase II, multicenter, study of oral cMET inhibitor INC280 in adult patients with EGFR wild-type (wt), advanced non-small cell lung cancer (NSCLC)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18119

A Phase 1b Study Evaluating the Safety, Tolerability and Immunogenicity of CMB305 (Sequentially Administered LV305 and G305) in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Cancer Type: Sarcoma

View Trial Details

CLINICAL TRIAL18321

Phase I/Ib trial of single agent PBF-509 and in combination with PDR001 for patients with advanced NSCLC

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18495

Caregiver Relationship Quality and Communication in Advanced Cancer Care

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18304

A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18517

A Randomized, Open-Label, Active-Controlled, Phase II Study of Intravenous Anetumab Ravtansine (BAY 94-9343) or Vinorelbine in Patients with Advanced or Metastatic Malignant Pleural Mesothelioma Overexpressing Mesothelin and Progressed on First Line Platinum/Pemetrexed-Based Chemotherapy

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18837

An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL17908

Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer (Screening Step)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18756

The Clinical Utility of a Blood-Based Multitranscriptome Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors

Cancer Type: Gastrointestinal Tumor

View Trial Details

CLINICAL TRIAL17970

A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL17969

Randomized Study of Erlotinib vs. Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18874

A Phase 1b/2 Study to Assess the Safety and Efficacy of HBI-8000 in Combination with Nivolumab in Patients with Advanced Solid Tumors Including Melanoma, Renal Cell Carcinoma (RCC) and Non-Small Cell Lung Cancer (NSCLC)

Cancer Type: Cutaneous

View Trial Details

CLINICAL TRIAL18915

A Phase 1 Trial of MLN0128 (TAK-228) in Combination with Osimertinib (AZD9291) in Advanced EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) After Progression on a Previous EGFR Tyrosine Kinase Inhibitor

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18825

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1522 in Patients with Advanced Breast Cancer and Other Advanced Tumors Expressing HER2

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18835

Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients with Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS Trial)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18999

Early Detection of Cancer Progression: Leveraging Team Science

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL17361

A Phase I/IB Trial of MEK162 in Combination with Erlotinib in NSCLC Harboring KRAS or EGFR Mutation

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18677

XALT3: Phase 3 Randomized Study Comparing X-396 to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18904

Contributors to and Correlates of Loneliness in Lung Cancer Patients

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18393

A Phase 1, Open-Label, Dose Escalation Study of MGA271 in Combination with Pembrolizumab in Patients with B7-H3-Expressing Melanoma, Squamous Cell Cancer of the Head and Neck, or Squamous Cell Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18685

Phase I/II, First-in-Human, Dose-Escalation Study of X-396 in Patients with Advanced Solid Tumors and Expansion Phase in Patients with ALK+ Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18537

A Phase 1b/2 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of a Novel Transforming Growth Factor-B Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumours (Phase 1b) and in Recurrent or Refractory Non-Small Cell Lung Cancer or Hepatocellular Carcinoma (Phase 2)

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18871

A Phase Ii, Open-Label, Multicenter, Single-Arm Study To Investigate TheEfficacy And Safety Of Atezolizumab As Neoadjuvant And Adjuvant Therapy In Patients With Stage Ib, Ii, Iiia Or Selected Iiib Resectable And Untreated Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18537

A Phase 1b/2 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of a Novel Transforming Growth Factor-B Receptor I Kinase Inhibitor (Galunisertib) Administered in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumours (Phase 1b) and in Recurrent or Refractory Non-Small Cell Lung Cancer or Hepatocellular Carcinoma (Phase 2)

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18871

A Phase Ii, Open-Label, Multicenter, Single-Arm Study To Investigate TheEfficacy And Safety Of Atezolizumab As Neoadjuvant And Adjuvant Therapy In Patients With Stage Ib, Ii, Iiia Or Selected Iiib Resectable And Untreated Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18428

A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18758

A Phase 1, Open-Label Dose Escalation Study of PF-04518600 as a Single Agent and in Combination with PF-05082566 in Patients with Selected Locally Advanced or Metastatic Carcinomas

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18494

A Phase I/II Study of Pembrolizumab and Vorinostat in Patients with Immune Therapy Naïve and Immune Therapy Pretreated Stage IV NSCLC

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18561

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158)

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18909

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18928

A Phase III, Randomized, Open Label Trial of Nivolumab in combination with Ipilimumab versus Pemetrexed with Cisplatin or Carboplatin as First Line Therapy in unresectable Pleural Mesothelioma

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18923

A Multi-Center Open-Label Phase 1/2 Study of BGB324 in Combination with Erlotinib in Patients with Stage IIIb or Stage IV Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL17985

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCB024360 in Combination With MEDI4736 in Subjects With Selected Advanced Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18844

A Phase 2 Study of Cediranib in Combination with Olaparib in Advanced Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL19067

A Phase 2 Single-arm Study to Evaluate Safety and Efficacy of CRS-207 with Pembrolizumab in Adults with Previously-Treated Malignant Pleural Mesothelioma

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL18811

Randomized, Double-Blind, Phase 2/3 Study in Subjects with Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 with Pemetrexed and Cisplatin (ATOMIC-Meso Phase 2/3 Study)

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19101

A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab anti-PD-1 Monoclonal Antibody) and in Combination with Both Nivolumab and Ipilimumab (anti-CTLA-4 Monoclonal Antibody) in Advanced Malignant Tumors

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19112

DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18914

Consolidative Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Based Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19114

Phase 1/2 Study to Evaluate the Safety and Preliminary Efficacy of Nivolumab Combined with Daratumumab in Participants with Advanced or Metastatic Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL19083

A Phase 1b/2, Open-Label, Randomized Study of Daratumumab Administered in Combination with Atezolizumab Compared with Atezolizumab Alone in Subjects with Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19082

A Phase I/Ib Trial of Pirfenidone Combined with Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19122

A Phase I Clinical Trial Combining Nivolumab and Tumor Infiltrating Lymphocytes (TIL) for Patients with Advanced Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19109

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-214 and Nivolumab in Patients with Select Locally Advanced or Metastatic Solid Tumor Malignancies

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL19320

An Open-Label, Multicenter Extension Study In Patients Previously Enrolled In A Genentech and/or F Hoffmann La Roche Ltd. Sponsored Atezolizumab Study

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19226

A Multicenter, Prospective, Open-Label, Non-Randomized Single-Arm Clinical Study Of The Safety And Tissue Response To Photodynamic Therapy Using Porfimer Sodium For Injection As Treatment For Solid Tumor In Peripheral Lung Prior To Surgical Resection

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19293

Phase 1b/2 Study Of VX15/2503 In Combination With Avelumab In Advanced Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19389

A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Subjects with Advanced Non-Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19406

Phase I/II Study of Nivolumab and Ipilimumab combined with Nintedanib in Non Small Cell Lung Cancer

Cancer Type: Thoracic

View Trial Details

CLINICAL TRIAL19228

A Phase 2, Multi-Center, Open Label Study of NIR178 in Combination with PDR001 in Patients with Selected Advanced Solid Tumors and Non-Hodgkin lymphoma

Cancer Type: Thoracic

View Trial Details